R Squared’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
R Squared's VRTX Position: Q2 2026 in Review
R Squared opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 1,337 shares worth $664K. The stake represents 0.35% of the portfolio and ranks #63 among its holdings. This is a return to the name: R Squared previously reported a position in VRTX as recently as Q3 2025.
R Squared first reported a position in VRTX in Q4 2024 and has held it in 3 quarters since. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- R Squared held 1,337 shares of Vertex Pharmaceuticals worth $664K as of Q2 2026.
- Vertex Pharmaceuticals was a new R Squared position in Q2 2026.
- Vertex Pharmaceuticals made up 0.35% of R Squared's portfolio in Q2 2026, its #63 holding.
- R Squared first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
- 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.